Logotype for Community Healthcare Trust Incorporated

Community Healthcare Trust (CHCT) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Community Healthcare Trust Incorporated

Q4 2024 earnings summary

30 Jun, 2026

Executive summary

  • Fourth quarter operations included selective acquisitions and ongoing redevelopment projects, with occupancy at 90.9% and average lease term at 6.7 years.

  • Acquired three physician clinics for $8.2 million, fully leased through 2029, and disposed of one property and a land parcel for $1.4 million in net proceeds.

  • For the year, nine properties acquired for $72.1 million, 99.3% leased, with leases through 2039 and returns of 9.1%-9.75%.

  • As of December 31, 2024, held investments in 200 properties across 36 states, totaling $1.2 billion and 4.4 million square feet.

  • Net income for Q4 2024 was $1.8 million, or $0.04 per diluted share, with FFO and AFFO at $0.48 and $0.55 per diluted share, respectively.

Financial highlights

  • Q4 total revenue was $29.3 million, nearly flat compared to $29.6 million in Q3; Q4 2024 rental income was $29.0 million, up from $28.1 million in Q4 2023.

  • Property operating expenses decreased by $500,000 quarter-over-quarter to $5.5 million; G&A expenses slightly down to $4.8 million, with 2024 G&A including $10.0 million in stock-based compensation.

  • Interest expense rose to $6.4 million from $6.3 million in Q3, reflecting higher borrowings and rate changes.

  • FFO for Q4 was $12.7 million, down 14.5% year-over-year, mainly due to lost rent and interest from a troubled tenant; FFO and AFFO per diluted share for Q4 2024 were $0.48 and $0.55, respectively, compared to $0.57 and $0.61 in Q4 2023.

  • AFFO was $14.6 million, flat sequentially but down 9% year-over-year; AFFO per share remained at $0.55.

Outlook and guidance

  • Two redevelopment projects expected to commence leases in Q2 2025.

  • Two properties under definitive purchase agreements for $33 million expected to close in Q1 2025, with returns of 9.5%-9.75%.

  • Entered agreements to acquire a residential treatment campus for $9.5 million and seven additional properties for $169.5 million, with expected returns of 9.1% to 9.75%.

  • Six additional properties under contract for $146 million, expected to close through 2025-2027; anticipates closing on one property in Q1 2025 and the remainder through 2027, but timing is not assured.

  • Annual acquisition target of $120-$150 million remains achievable, with a focus on accretive deals; occupancy expected to remain in the 91%-93% range, with redevelopment projects providing a tailwind.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more